Impact of the first booster vaccine against SARS-CoV-2 in Chile
| dc.contributor.author | Molina Emilio | |
| dc.contributor.author | Olguín Diego | |
| dc.contributor.author | Brault Antoine | |
| dc.contributor.author | Uribe Paula | |
| dc.contributor.author | Gajardo Pedro | |
| dc.contributor.author | Canals Mauricio | |
| dc.contributor.author | Ramírez Héctor | |
| dc.date.accessioned | 2026-05-19T08:33:35Z | |
| dc.date.issued | 2026-6 | |
| dc.identifier.doi | 10.1016/j.idm.2025.12.009 | |
| dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/12677 | |
| dc.identifier.uri.pubmed | https://doi.org/10.1016/j.idm.2025.12.009 | |
| dc.source | Infectious Disease Modelling | |
| dc.title | Impact of the first booster vaccine against SARS-CoV-2 in Chile |
